SAN DIEGO, CA — Evofem, Inc. announces that Dr. Kelly Culwell has been named Chief Medical Officer, effective immediately. In this role, Dr. Culwell will provide medical oversight, expertise and leadership to ensure the delivery of quality healthcare products. She will report to Evofem CEO, Saundra Pelletier.
“Kelly’s knowledge, enthusiasm and work in developing global guidelines for clinical practice in women’s health will make her an asset to the Evofem team,” said Pelletier.
In addition to her duties as CMO, Dr. Culwell is a Volunteer Clinical Professor in the Department of Obstetrics and Gynecology at the University of California, San Diego and Davis campuses. Prior to Evofem, Dr. Culwell served as Medical Director of the Planned Parenthood of the Pacific Southwest. Her previous experience includes Medical Advisor to the International Planned Parenthood Federation and Medical Officer with the World Health Organization.
Dr. Culwell has published widely in journals including Contraception, the International Journal of Gynecology and Obstetrics, and Obstetrics & Gynecology. She completed her medical training and residency at the University of California, Davis and University of California, San Diego, respectively. She earned a Master of Public Health from Northwestern University, where she also completed a fellowship in family planning and contraception.
About Evofem, Inc.
Evofem, Inc. is a privately held biotechnology company that discovers, develops and commercializes prescription and over-the-counter products in the areas of feminine care, contraception, and the prevention of sexually transmitted infections. Evofem, Inc. is committed to delivering effective, woman-controlled, rapidly reversible forms of contraception to women globally.